Update: Advancing CNS-penetrant ATR inhibitors with Enki™
Building on their initial hit series, Variational AI and Rakovina Therapeutics share promising new results on ATR inhibitors generated with Enki. The latest findings reveal compounds that balance potency, selectivity,… Read More
Variational AI Enters Collaboration with Merck to Apply Generative AI to Drug Discovery
Variational AI, Inc., a generative AI drug discovery company, announced a collaboration with Merck, known as MSD outside of the United States and Canada, to apply Variational AI’s Enki™ platform… Read More
Variational AI & Life Chemicals join forces to discover selective dual EGFR/FGFR1 inhibitors using generative AI
Following their successful 2022 collaboration, which targeted the SARS-CoV-2 main protease, Variational AI and Life Chemicals have partnered for a second time to discover de novo generated selective dual EGFR/FGFR1… Read More
Variational AI Joins Agora Open Science Trust to Advance PRMT6 Inhibitors for SBMA
Variational AI is proud to announce its participation in a new open science drug discovery initiative led by Agora Open Science Trust. The project is focused on optimizing the potency… Read More
Variational AI Named “Emerging Company of the Year – Biotech” by Life Sciences BC
Variational AI is proud to announce that it has been named Emerging Company of the Year – Biotech by Life Sciences BC. This award highlights Variational AI’s innovation in developing… Read More
Variational AI and Oncocross to Collaborate on AI-Driven Drug Discovery Program in Atopic Dermatitis
Variational AI announces a co-development agreement with Oncocross, to co-develop a novel small molecule inhibitor for chronic skin inflammation focusing on atopic dermatitis. Read More
News & Press
Upcoming Events
Variational AI at AI Convergence: Small Molecule Discovery Summit 2026
Variational AI is excited to participate in the inaugural AI Convergence: Small Molecule Discovery Summit in Boston, bringing together leaders at the intersection of AI/ML, computational chemistry, and medicinal chemistry.…
Event Dates
18–20 March, 2026
Location
Boston, MA
Variational AI at JPM Week and Biotech Showcase 2026
Each January, the J.P. Morgan Healthcare Conference turns San Francisco into the global epicenter of biotech, pharma, and healthcare investing. It is widely regarded as the industry’s largest and most…
Event Dates
12–15 January, 2026
Location
San Francisco, CA
